<DOC>
	<DOCNO>NCT00000341</DOCNO>
	<brief_summary>The purpose study evaluate steady-state pharmacokinetics bioavailability buprenorphine sublingual tablet vs. sublingual solution .</brief_summary>
	<brief_title>Evaluation Liquid vs. Tablet Buprenorphine - 6</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>M/F age 2150 . Meet DSMIV criterion opioid dependence . Agree condition study sign inform consent . Psychiatric disorder require medication therapy . History seizure . Pregnant and/or nuring woman . Dependence ETOH benzodiazepine sedative/hypnotics . Acute hepatitis . Other medical condtions deem participation unsafe .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>opioid dependence</keyword>
</DOC>